| Management target | Revenue FY27 |
|---|
| Revenue growth | 20% YoY growth driven by consumer and engineering segments. |
|---|---|
| Margins | Temporary contraction due to Roha startup and legacy project overhang. |
| Order book | Healthy order backlog of 2,473 Cr excluding recent 52M USD win. |
| Demand visibility | Strong pipeline in semiconductors, green hydrogen, and international markets. |
| Management confidence | Balanced, acknowledging short-term margin pain for long-term structural shifts. |
Growth
Revenue grew 20% YoY to 701 Cr, with Consumer products up 33% and Engineering up 14%.
Outlook
Targeting 25% utilization for Roha plant in FY27; aiming for double-digit specialty chemical margins long-term.
Risks
Margins under pressure from legacy UP projects and 6% specialty chemical erosion due to Roha costs.
Last quarter's promises, checked
Delivered
- Guided Roha commissioning → Fully commissioned and certified (WQA) (= BEAT)
- Guided 34% Consumer growth → Delivered 33-34% growth (= BEAT)
Partly delivered
- Guided margin stability → EBITDA down 29% YoY due to Roha/Logistics (= PARTIAL)
Missed
- Guided legacy project closure in FY26 → 30% scope still pending (= MISS)
- Guided 25-30% Roha utilization → Not achieved due to West Asia crisis (= MISS)
Earnings Call Transcript filed with NSE, NSE: IONEXCHANG. Summary written with AI assistance from the document.
Ion Exchange (India) Ltd: key numbers
- Share price
- ₹326.05
- Market cap
- ₹4,782 Cr
- Revenue (annual)
- ₹2,915 Cr
- Net profit (annual)
- ₹142.7 Cr
- P/E (TTM)
- -147.1×Sector 21.7×
- Promoter holding
- 25.08%-0.35% QoQ
- FII holding
- 4.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ion Exchange (India) Ltd
All →Ion Exchange (India) Earnings Call Transcript: Key Takeaways
Q2 FY27 EBITDA loss of ₹848 Mn and net loss of ₹828 Mn on ~8% revenue decline. Legacy-project overrun booked in one go. H2 recovery depends on deferred dispatches and the Hyundai order.
Ion Exchange (India) Investor Presentation: Key Takeaways
Q2 FY27 consolidated operating loss: operating income INR 6,747 Mn (-8.1% YoY), EBITDA INR (848) Mn, PAT INR (828) Mn, driven by legacy project cost revisions.
Ion Exchange (India) Management Change
Ion Exchange's board approved redesignating Executive Chairman Rajesh Sharma as Non-Executive Non-Independent Chairman, effective 1 January 2027. The change needs shareholder approval via postal ballot.
Ion Exchange (India) Q2 FY27 Results: Net Loss of ₹82.8 Cr
Ion Exchange (India) Ltd reported revenue from operations of ₹674.7 Cr (-8.1% YoY) and a net loss of ₹82.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹82.8 Cr
Ion Exchange (India) Board Meeting Date
Ion Exchange India gave prior intimation of a November 3, 2026 board meeting to consider unaudited Q2 and H1 results. The filing is a future meeting notice with no results figures attached.
Ion Exchange (India) Other Announcement
Ion Exchange (India) Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulation 31(1)(b).